Literature DB >> 30221171

Role of alternative splicing in hematopoietic stem cells during development.

Yimeng Gao1, Radovan Vasic1, Stephanie Halene1.   

Abstract

Year:  2018        PMID: 30221171      PMCID: PMC6131231          DOI: 10.21037/sci.2018.08.02

Source DB:  PubMed          Journal:  Stem Cell Investig        ISSN: 2306-9759


× No keyword cloud information.
  24 in total

1.  Differential mRNA processing in hematopoietic stem cells.

Authors:  Teresa V Bowman; Andrew J McCooey; Akil A Merchant; Carlos A Ramos; Patricia Fonseca; Alan Poindexter; Steven B Bradfute; Daniela M Oliveira; Rahshaana Green; Yayun Zheng; Kathyjo A Jackson; Stuart M Chambers; Shannon L McKinney-Freeman; Kevin G Norwood; Gretchen Darlington; Preethi H Gunaratne; David Steffen; Margaret A Goodell
Journal:  Stem Cells       Date:  2005-12-22       Impact factor: 6.277

Review 2.  The SR protein family of splicing factors: master regulators of gene expression.

Authors:  Jennifer C Long; Javier F Caceres
Journal:  Biochem J       Date:  2009-01-01       Impact factor: 3.857

3.  A CLK3-HMGA2 Alternative Splicing Axis Impacts Human Hematopoietic Stem Cell Molecular Identity throughout Development.

Authors:  Marcella Cesana; Michael H Guo; Davide Cacchiarelli; Lara Wahlster; Jessica Barragan; Sergei Doulatov; Linda T Vo; Beatrice Salvatori; Cole Trapnell; Kendell Clement; Patrick Cahan; Kaloyan M Tsanov; Patricia M Sousa; Barbara Tazon-Vega; Adriano Bolondi; Federico M Giorgi; Andrea Califano; John L Rinn; Alexander Meissner; Joel N Hirschhorn; George Q Daley
Journal:  Cell Stem Cell       Date:  2018-04-05       Impact factor: 24.633

4.  SRSF1-Regulated Alternative Splicing in Breast Cancer.

Authors:  Olga Anczuków; Martin Akerman; Antoine Cléry; Jie Wu; Chen Shen; Nitin H Shirole; Amanda Raimer; Shuying Sun; Mads A Jensen; Yimin Hua; Frédéric H-T Allain; Adrian R Krainer
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

5.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia.

Authors:  Lili Wang; Michael S Lawrence; Youzhong Wan; Petar Stojanov; Carrie Sougnez; Kristen Stevenson; Lillian Werner; Andrey Sivachenko; David S DeLuca; Li Zhang; Wandi Zhang; Alexander R Vartanov; Stacey M Fernandes; Natalie R Goldstein; Eric G Folco; Kristian Cibulskis; Bethany Tesar; Quinlan L Sievers; Erica Shefler; Stacey Gabriel; Nir Hacohen; Robin Reed; Matthew Meyerson; Todd R Golub; Eric S Lander; Donna Neuberg; Jennifer R Brown; Gad Getz; Catherine J Wu
Journal:  N Engl J Med       Date:  2011-12-12       Impact factor: 91.245

6.  Frequent pathway mutations of splicing machinery in myelodysplasia.

Authors:  Kenichi Yoshida; Masashi Sanada; Yuichi Shiraishi; Daniel Nowak; Yasunobu Nagata; Ryo Yamamoto; Yusuke Sato; Aiko Sato-Otsubo; Ayana Kon; Masao Nagasaki; George Chalkidis; Yutaka Suzuki; Masashi Shiosaka; Ryoichiro Kawahata; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Ken Ishiyama; Hiraku Mori; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Sumio Sugano; Claudia Haferlach; H Phillip Koeffler; Lee-Yung Shih; Torsten Haferlach; Shigeru Chiba; Hiromitsu Nakauchi; Satoru Miyano; Seishi Ogawa
Journal:  Nature       Date:  2011-09-11       Impact factor: 49.962

7.  Transcriptional diversity during lineage commitment of human blood progenitors.

Authors:  Lu Chen; Myrto Kostadima; Joost H A Martens; Nicole Soranzo; Willem H Ouwehand; Hendrik G Stunnenberg; Mattia Frontini; Augusto Rendon; Giovanni Canu; Sara P Garcia; Ernest Turro; Kate Downes; Iain C Macaulay; Ewa Bielczyk-Maczynska; Sophia Coe; Samantha Farrow; Pawan Poudel; Frances Burden; Sjoert B G Jansen; William J Astle; Antony Attwood; Tadbir Bariana; Bernard de Bono; Alessandra Breschi; John C Chambers; Bridge Consortium; Fizzah A Choudry; Laura Clarke; Paul Coupland; Martijn van der Ent; Wendy N Erber; Joop H Jansen; Rémi Favier; Matthew E Fenech; Nicola Foad; Kathleen Freson; Chris van Geet; Keith Gomez; Roderic Guigo; Daniel Hampshire; Anne M Kelly; Hindrik H D Kerstens; Jaspal S Kooner; Michael Laffan; Claire Lentaigne; Charlotte Labalette; Tiphaine Martin; Stuart Meacham; Andrew Mumford; Sylvia Nürnberg; Emilio Palumbo; Bert A van der Reijden; David Richardson; Stephen J Sammut; Greg Slodkowicz; Asif U Tamuri; Louella Vasquez; Katrin Voss; Stephen Watt; Sarah Westbury; Paul Flicek; Remco Loos; Nick Goldman; Paul Bertone; Randy J Read; Sylvia Richardson; Ana Cvejic
Journal:  Science       Date:  2014-09-26       Impact factor: 47.728

8.  The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation.

Authors:  Olga Anczuków; Avi Z Rosenberg; Martin Akerman; Shipra Das; Lixing Zhan; Rotem Karni; Senthil K Muthuswamy; Adrian R Krainer
Journal:  Nat Struct Mol Biol       Date:  2012-01-15       Impact factor: 15.369

9.  SF3B1 mutations are associated with alternative splicing in uveal melanoma.

Authors:  Marc-Henri Stern; Richard Marais; Simon J Furney; Malin Pedersen; David Gentien; Amaury G Dumont; Audrey Rapinat; Laurence Desjardins; Samra Turajlic; Sophie Piperno-Neumann; Pierre de la Grange; Sergio Roman-Roman
Journal:  Cancer Discov       Date:  2013-07-16       Impact factor: 39.397

10.  Selective blockade of microRNA processing by Lin28.

Authors:  Srinivas R Viswanathan; George Q Daley; Richard I Gregory
Journal:  Science       Date:  2008-02-21       Impact factor: 47.728

View more
  1 in total

Review 1.  Alternative Splicing in Myeloid Malignancies.

Authors:  Carmelo Gurnari; Simona Pagliuca; Valeria Visconte
Journal:  Biomedicines       Date:  2021-12-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.